Trial Profile
Prospective study to investigate effect of vildagliptin on β-cell dysfunction and insulin resistance in Type-2 diabetes mellitus patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Dec 2015
Price :
$35
*
At a glance
- Drugs Vildagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics; Therapeutic Use
- 12 Dec 2015 New trial record